Bundled Cancer Screening and Genetic Services Navigation (NCT07228000)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this study is to test bundled familial cancer risk assessment + multicancer (colorectal + breast) vs. single (breast) cancer navigation, using a wait list control for colorectal cancer screening referral and navigation. Among those eligible, this study will test usual care referral to genetic services vs. pretest education + usual care referral. The study also will assess how bundled multicancer navigation works and for whom it is most effective through a multisite, mixed-methods patient- and organization-level process evaluation.
Who can join: Review the eligibility criteria below.
Location: ChristianaCare-Helen F. Graham Cancer Center & Research Institute — Newark, Delaware
Age range: 45 Years to 74 Years
🧪 Interventions in This Study
- Breast cancer screening navigation (BEHAVIORAL)
- Multicancer screening navigation (BEHAVIORAL)
- Usual care genetics referral (BEHAVIORAL)
- Pretest education + usual care genetics referral (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- ChristianaCare-Helen F. Graham Cancer Center & Research Institute — Newark, Delaware
- Georgetown University — Washington D.C., District of Columbia
📞 Contact the Study Coordinator
Phone: (202) 687-0869
Email: sco4@georgetown.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Cancer Screening
- Project 1: Self-Triage by 2D Full-field Digital Mammography or Synthetic Images — Boston, Massachusetts
- MADRE (Mammograms Available Due to Research and Education) — Chicago, Illinois
- Women Informed to Screen Depending on Measures of Risk (Wisdom Study) — Birmingham, Alabama
- B.Brilliant Revelation Comparision Study — Philadelphia, Pennsylvania
- A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients — Los Angeles, California
Explore by condition: All Breast Cancer Screening clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.